Retrospective Study
Copyright ©The Author(s) 2024.
World J Gastrointest Surg. Aug 27, 2024; 16(8): 2574-2582
Published online Aug 27, 2024. doi: 10.4240/wjgs.v16.i8.2574
Table 1 Comparison of general data between the validation and modeling groups
General informationThe validation groups (n = 38)The modeling groups (n = 152)t/χ2P value
Age (years)60.83 ± 12.1661.52 ± 11.850.3190.750
GenderMale16924.2050.122
Female2260
BMI (kg/m2)21.16 ± 2.4621.37 ± 2.110.5300.597
Primary diseaseMalignant biliary and pancreatic tumors20770.0470.977
Other biliary diseases1875
HypertensionYes8350.0680.967
No30117
DiabetesYes7300.0340.983
No31122
JaundiceYes12621.0850.581
No2690
Opioid useYes13550.0510.975
No2597
Gastrointestinal obstructionYes15580.0220.989
No2394
Table 2 Univariate analysis of factors influencing preoperative gastric retention in endoscopic retrograde cholangiopancreatography patients
General informationThe gastric retention group (n = 52)Non-gastric retention group (n = 100)t/χ2P value
Age (years)60.55 ± 10.1660.50 ± 10.450.0280.978
GenderMale177525.631< 0.001
Female3525
BMI (kg/m2)21.39 ± 2.2221.35 ± 2.140.1080.914
Primary diseaseMalignant biliary and pancreatic tumors393818.741< 0.001
Other biliary diseases1362
HypertensionYes15201.5100.470
No3780
DiabetesYes8220.9450.623
No4478
JaundiceYes323014.0900.001
No2070
Opioid useYes282710.6800.005
No2473
Gastrointestinal obstructionYes27316.3470.042
No2569
Table 3 Multivariate logistic regression analysis of factors influencing preoperative gastric retention in endoscopic retrograde cholangiopancreatography patients
Risk factors
β
SE
Ward
OR
95%CI
P value
Gender0.883 0.3615.988 2.4191.192-4.908 < 0.001
Primary disease1.199 0.3859.695 3.3161.559-7.052 < 0.001
Jaundice1.072 0.3728.303 2.9211.409-6.056 < 0.001
Opioid use1.152 0.4018.251 3.1641.442-6.943 < 0.001
Gastrointestinal obstruction1.242 0.412 9.085 3.4621.544-7.763 < 0.001